The University of Southampton
University of Southampton Institutional Repository

Pharmacological treatment of social phobia

Pharmacological treatment of social phobia
Pharmacological treatment of social phobia
Social phobia is a common and disabling anxiety disorder that tends to have an early onset and runs a chronic course. It is characterized by a marked fear of negative evaluation in social or performance situations, and typically results in significant problems in social and professional relationships and lower levels of educational achievement and paid employment. It can occur as a separate entity or with comorbid conditions such as depression, alcohol abuse or other anxiety disorders. This contribution provides an overview of the pharmacological treatment of social phobia. Many treatments have been found efficacious in acute treatment, and the choice of a particular agent will be dependent on factors such as longer-term efficacy, side-effect profile and the risk of drug interactions. The most frequently suggested first-line treatment is a selective serotonin reuptake inhibitor (SSRI), but other effective treatments include venlafaxine, phenelzine and alprazolam. Some psychological therapies, in particular cognitive–behaviour therapy (CBT), have also been found efficacious.
social phobia, drug treatment, social anxiety disorder
217-223
Bhogal, Kuljit S.
abf6a86f-66e3-4150-8c13-d7b46f684d58
Baldwin, David S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Bhogal, Kuljit S.
abf6a86f-66e3-4150-8c13-d7b46f684d58
Baldwin, David S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e

Bhogal, Kuljit S. and Baldwin, David S. (2007) Pharmacological treatment of social phobia. Psychiatry, 6, 217-223. (doi:10.1016/j.mppsy.2007.02.007).

Record type: Article

Abstract

Social phobia is a common and disabling anxiety disorder that tends to have an early onset and runs a chronic course. It is characterized by a marked fear of negative evaluation in social or performance situations, and typically results in significant problems in social and professional relationships and lower levels of educational achievement and paid employment. It can occur as a separate entity or with comorbid conditions such as depression, alcohol abuse or other anxiety disorders. This contribution provides an overview of the pharmacological treatment of social phobia. Many treatments have been found efficacious in acute treatment, and the choice of a particular agent will be dependent on factors such as longer-term efficacy, side-effect profile and the risk of drug interactions. The most frequently suggested first-line treatment is a selective serotonin reuptake inhibitor (SSRI), but other effective treatments include venlafaxine, phenelzine and alprazolam. Some psychological therapies, in particular cognitive–behaviour therapy (CBT), have also been found efficacious.

Full text not available from this repository.

More information

Published date: May 2007
Keywords: social phobia, drug treatment, social anxiety disorder

Identifiers

Local EPrints ID: 62325
URI: https://eprints.soton.ac.uk/id/eprint/62325
PURE UUID: 843b8a38-fb6f-43a0-a0a1-55d6ce052769

Catalogue record

Date deposited: 12 Sep 2008
Last modified: 13 Mar 2019 20:27

Export record

Altmetrics

Contributors

Author: Kuljit S. Bhogal

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×